Résultat de recherche

Résultats de recherche par année 1995 1995 1998 2002 2007 2016

• 16 Article
• 2 Letter

Résultats de recherche par année

Résultats de recherche par année

Rechercher les résultats

• 2016

  Extending aromatase-inhibitor adjuvant therapy to 10 years

  Goss, P. E., Ingle, J. N., Pritchard, K. I., Robert, N. J., Muss, H., Gralow, J., Gelmon, K., Whelan, T., Strasser-Weippl, K., Rubin, S., Sturtz, K., Wolff, A. C., Winer, E., Hudis, C., Stopeck, A., Beck, J. T., Kaur, J. S., Whelan, K., Tu, D. & Parulekar, W. R., juill. 21 2016, Dans: New England Journal of Medicine. 375, 3, p. 209-219 11 p.

  Résultat de recherche: Article › examen par les pairs

  Accès libre

  • Aromatase Inhibitors 100%
  • Letrozole 86%
  • Placebos 55%
  • Breast Neoplasms 34%
  • Confidence Intervals 32%
  536 Citations (Scopus)
• 2014

  What should men living with haemophilia need to know? The perspectives of Canadian men with haemophilia

  Arnold, E., Lane, S., Webert, K. E., Chan, A., Walker, I., Tufts, J., Rubin, S., Poon, M. C. & Heddle, N. M., 2014, Dans: Haemophilia. 20, 2, p. 219-225 7 p.

  Résultat de recherche: Article › examen par les pairs

  • Hemophilia A 100%
  • Disease Management 19%
  • Sexual Behavior 19%
  • Safety 11%
  • Complementary Therapies 9%
  13 Citations (Scopus)
• 2013

  Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17

  Vickers, M. M., Karapetis, C. S., Tu, D., O'Callaghan, C. J., Price, T. J., Tebbutt, N. C., Van Hazel, G., Shapiro, J. D., Pavlakis, N., Gibbs, P., Blondal, J., Lee, U., Meharchand, J. M., Burkes, R. L., Rubin, S. H., Simes, J., Zalcberg, J. R., Moore, M. J., Zhu, L. & Jonker, D. J., avr. 2013, Dans: Annals of Oncology. 24, 4, p. 953-960 8 p.

  Résultat de recherche: Article › examen par les pairs

  Accès libre

  • Cetuximab 100%
  • Survival 44%
  • Exanthema 39%
  • Colorectal Neoplasms 31%
  • Anorexia 21%
  41 Citations (Scopus)
• 2011

  Bortezomib added to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: A phase II study by the National Cancer Institute of Canada clinical trials group

  Sehn, L. H., MacDonald, D., Rubin, S., Cantin, G., Rubinger, M., Lemieux, B., Basi, S., Imrie, K., Gascoyne, R. D., Sussman, J., Chen, B. E., Djurfeldt, M., Shepherd, L., Couban, S. & Crump, M., sept. 1 2011, Dans: Journal of Clinical Oncology. 29, 25, p. 3396-3401 6 p.

  Résultat de recherche: Article › examen par les pairs

  • Follicular Lymphoma 100%
  • Bortezomib 99%
  • National Cancer Institute (U.S.) 94%
  • Rituximab 88%
  • Vincristine 87%
  29 Citations (Scopus)
• 2010

  Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia

  Shustik, C., Turner, A. R., Desjardins, P., Fernandez, L., Rubin, S., Larratt, L., Duncan, A. M. V., Rizi, D., Sadura, A., Shepherd, L., Li, D., Rassenti, L. & Kipps, T., janv. 2010, Dans: Leukemia. 24, 1, p. 237-239 3 p.

  Résultat de recherche: Letter › examen par les pairs

  Accès libre
  8 Citations (Scopus)
• 2007

  A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7

  Shustik, C., Belch, A., Robinson, S., Rubin, S. H., Dolan, S. P., Kovacs, M. J., Grewal, K. S., Walde, D., Barr, R., Wilson, J., Gill, K., Vickars, L., Rudinskas, L., Sicheri, D. A., Wilson, K., Djurfeldt, M., Shepherd, L. E., Ding, K. & Meyer, R. M., janv. 2007, Dans: British Journal of Haematology. 136, 2, p. 203-211 9 p.

  Résultat de recherche: Article › examen par les pairs

  • Melphalan 100%
  • Prednisone 83%
  • Multiple Myeloma 80%
  • Dexamethasone 75%
  • Observation 58%
  72 Citations (Scopus)

• Central nervous system graft-versus-host disease presenting with granulomatous encephalitis [4]

  Kew, A. K., Macaulay, R., Burrell, S., Rubin, S., Dow, G. & Couban, S., juill. 2007, Dans: Bone Marrow Transplantation. 40, 2, p. 183-184 2 p.

  Medicine

  Résultat de recherche: Letter › examen par les pairs
  19 Citations (Scopus)
• 2005

  Prevalence of conditions associated with human immunodeficiency and hepatits virus infections among persons with haemophilia, 2001-2003

  Goedert, J. J., Siegel, J., Miller, K., Lederman, M. M., Thompson, A., Browning, B., Gamerman, S., McRedmond, K., Withycombe, J., Gruppo, R., Stack, G., Lusher, J., Percy, L., Nugent, D., McDaniel, M., Manno, C., Butler, R., Wade, A., Angiolillo, A., Luban, N. L. C., & 79 autresGuelcher, C., Tarantino, M., Greer, S., Gill, J., Nelson, J., White, G., Fried, M., Grimsley, A. L., DiMichele, D., Goldberg, I., French, J., Hibner, S., Steinberg, J., Faust, S., Key, N., Hannemann, V., Kessler, C. M., Lee, A. E., Eyster, M. E., Galli, K., Jenkins, G., Bernstein, Z. P., Belling, L., Shapiro, A., Halley, M., Noblet, P., Jardine, L., Laudenbach, L., Lipton, R., Pece, C., Leissinger, C. A., Schmidt, C., Carr, M., Nolte, M., Manco-Johnson, M., Giambartolomei, S., Rubin, S. H., Belliveau, D., Aledort, L., McCarthy, J., Lemons, R., Bleak, S., Kraut, E., Witkoff, L., Sexauer, C., Kiplinger, F., Thompson, A., Cooper, C., Britton, H., Cobb, K., Reimers, H. J., Bagato, J. A., Powell, J. S., Herr, M., Scott, K., Hutter, J., Damiano, M. L., Navarro, W., Roth, J., Palascak, J., Sherman, K., Heffner, M., DiPaolo, J., Lammer, M., Iyer, R., Matthew, P., Schwartz, M., Konkle, B., Vijayanathan, N., Dugdale, M., Lilley, D., Hoots, K., Brown, D., Ullman, M., Neff, A., Klintworth, S., Sabio, H., Smith, A. & Karafoulidou, A., sept. 2005, Dans: Haemophilia. 11, 5, p. 516-528 13 p.

  Résultat de recherche: Article › examen par les pairs

  • Hemophilia A 100%
  • HIV-1 76%
  • Virus Diseases 65%
  • HIV 60%
  • Hepacivirus 49%
  30 Citations (Scopus)
• 2002

  Efficacy and safety of the factor VIII/von Willebrand factor concentrate, Haemate-P/Humate-P: Ristocetin cofactor unit dosing in patients with von Willebrand disease

  Lillicrap, D., Poon, M. C., Walker, I., Xie, F., Schwartz, B. A., Akabutu, J., Ali, K., Barnard, D., Blanchette, V., Bond, M., Carcao, M., Card, R., David, M., Davis, J., Delorme, M., Demers, C., Dolan, S., Drouin, J., Garvey, B., Gill, K., & 20 autresGrowe, G., Herst, J., Israels, S., Lepine-Martin, M., Luke, K. H., McCusker, P., Pai, M., Ritchie, B., Rivard, G., Robinson, S., Ross, E., Rubin, S., Rubinger, M., Scully, M. F., Silva, M., St.-Louis, J., Stobart, K., Teitel, J., Vickars, L. & Wu, J., 2002, Dans: Thrombosis and Haemostasis. 87, 2, p. 224-230 7 p.

  Résultat de recherche: Article › examen par les pairs

  • human F8 protein 100%
  • factor VIII, von Willebrand factor drug combination 97%
  • von Willebrand Diseases 88%
  • von Willebrand Factor 72%
  • Safety 38%
  113 Citations (Scopus)

• Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: A trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer

  Shepherd, F. A., Giaccone, G., Seymour, L., Debruyne, C., Bezjak, A., Hirsh, V., Smylie, M., Rubin, S., Martins, H., Lamont, A., Krzakowski, M., Sadura, A. & Zee, B., nov. 15 2002, Dans: Journal of Clinical Oncology. 20, 22, p. 4434-4439 6 p.

  Résultat de recherche: Article › examen par les pairs

  • marimastat 100%
  • National Cancer Institute (U.S.) 64%
  • Small Cell Lung Carcinoma 62%
  • Canada 50%
  • Organizations 46%
  246 Citations (Scopus)

• The North American Immune Tolerance Registry: Practices, outcomes, outcome predictors

  DiMichele, D. M., Kroner, B. L., Adair, S., Addiego, J., Anderson, V., Barbosa, J., Blatt, P., Bockenstedt, P., Castle, V., Chenaille, P., Cohen, J., Czapek, E., Davis, J., Davignon, G., De Alarcon, P., Dubowy, R., DuCore, J., Dugdale, M., Ewenstein, B., Fahner, J., & 51 autresGribble, T. J., Gnarra, D., Gruppo, R., Hakami, N., Hanna, M., Hanna, W., Haut, P., Heggie, G., Homans, A., Hutter, J., Johnson, C., Kajani, M., Karpatkin, M., Kasper, C., Katz, J., Kessler, C., Key, N., Koerper, M., Konkle, B., Kosinski, R., Lazerson, J., Lightsey, A., Loew, T., Lusher, J., MacLaughlin, W., Manco-Johnson, M., Manno, C., McRedmond, K., Phatak, P., Powell, J., Ragni, M., Rosenfield, C., Sanders, J., Santiago-Borrero, P., Saidi, P., Seeler, R., Seremetis, S., Sexauer, J., Travis, S., Valdez, L., Warner, E., White, G., Barrand, D., Drown, J., Herst, J., Inwood, M., Lillicrap, D., Rivard, G., Rubin, S., Stranczyniski, H. & Teitel, J., 2002, Dans: Thrombosis and Haemostasis. 87, 1, p. 52-57 6 p.

  Résultat de recherche: Article › examen par les pairs

  • Immune Tolerance 100%
  • Hemophilia A 93%
  • Registries 65%
  • Hemophilia B 27%
  • Nephrotic Syndrome 23%
  258 Citations (Scopus)
• 2001

  Immune tolerance in hemophilia with factor VIII inhibitors: Predictors of success

  Mariana, G., Kroner, B., Miller, R. T., Ewing, N. P., Butler, R., Morfini, M., Bell, B., Fressinaud, E., Gringeri, A., Kisker, C. T., Kessler, C., Gill, J. C., Scharrer, I., Arcieri, P., Zimmermann, R., White, G. C., Mariani, G., Growe, G. H., Di Michele, D., Nagao, T., & 31 autresBrackmann, H. H., Mauser Bunschoten, E. P., Balocchi, A., Thompson, A. R., Inwood, M. J., Brettler, D. B., Magallon Martinez, M., Scheibel, E., Beardsley, D. S., Menza, L., Mancc-Johnson, M., Tusell, J., Chiu Poon, M., Walker, I., Rodeghiero, F., Bond, M., Rasi, V., Sultan, Y., Rubin, S. H., Blei, F., Guerois, C., Ciavarella, N., Berrettini, M., Peerlinck, K., Lusher, J., Wicklund, B. M., Lenk, H., Goudemand, J., Ekert, H., Korper, M. A. & D'Oiron, R., 2001, Dans: Haematologica. 86, 11, p. 1186-1193 8 p.

  Résultat de recherche: Article › examen par les pairs

  • Immune Tolerance 100%
  • Hemophilia A 93%
  • Factor VIII 92%
  • Registries 21%
  • Isoantibodies 18%
  138 Citations (Scopus)
• 1998

  A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting Factor VIII:C inhibitors in the haemophilia A population of Canada

  Giles, A. R., Verbruggen, B., Rivard, G. E., Teitel, J., Walker, I., Growe, G., Poon, M. C., Wu, J., Card, R., Ali, K., Israels, S., Rubinger, M., Herst, J., Gill, K., Inwood, M., McCusker, P. J., Pai, M., Garvey, B., Blanchette, V., Giles, A., & 18 autresLillicrap, D., Silva, M., Drouin, J., Luke, K. H., Bond, M., David, M., Rivard, G., St-Louis, J., Lepine-Martin, M., Demers, C., Jobin, F., Scully, M. F., Dolan, S., Rubin, S., Barnard, D., Robinson, S., Ross, E. & Jardine, L., avr. 1998, Dans: Thrombosis and Haemostasis. 79, 4, p. 872-875 4 p.

  Medicine

  Résultat de recherche: Article › examen par les pairs

  • Hemophilia A 100%
  • Factor VIII 99%
  • Canada 80%
  • imidazole 38%
  • Population 34%
  141 Citations (Scopus)

• Causes of death in Canadians with haemophilia 1980-1995

  Walker, I. R., Julian, J. A., Growe, G., Davis, J., Vickars, L., Akabutu, J., Ritchie, B., Poon, M. C., Wu, J., Card, R., Ali, K., Israels, S., Rubinger, M., Stobard, K., Inwood, M., McCusker, P., Walker, I., Pai, M., Teitel, J., Garvey, B., & 22 autresBlanchette, V., Giles, A., Lillicrap, D., Silva, M., Drouin, J., Luke, K. H., Gill, K., Herst, J., Lepine-Martin, M., Rivard, G., Bond, M., David, M., St.-Louis, J., Jobin, F., Demers, C., Jardine, L., Scully, M. F., Barnard, D., Robinson, S., Rubin, S., Dolan, S. & Ross, E., 1998, Dans: Haemophilia. 4, 5, p. 714-720 7 p.

  Medicine

  Résultat de recherche: Article › examen par les pairs

  • Hemophilia A 100%
  • Cause of Death 70%
  • Life Expectancy 50%
  • HIV Antibodies 48%
  • HIV 34%
  67 Citations (Scopus)

• Randomized trial of interferon-α maintenance in myeloma patients responding to melphalan and prednisone (MY-6)

  Bergsagel, D. E., Browman, G., Sicheri, D., O'Reilly, S., Wilson, K. S., Rubin, S., Belch, A., Shustik, C., Barr, R., Walker, I., James, K., Zee, B. & Johnston, D., 1998, Dans: Cancer Research Therapy and Control. 6, 1-4, p. 129-131 3 p.

  Résultat de recherche: Article › examen par les pairs
• 1996

  The International Registry of Immune Tolerance: 1994 update

  Ghirardini, A., Puopolo, M., Chiarotti, F., Mariani, G., Brettler, D. B., Peerlink, K., Beardsley, D. S., Bell, B. A., Berrettini, M., Blei, F., Ballocchi, A., Butler, R., Ciavarella, N., Ewing, N. P., Fressinaud, E., Ghirardini, A., Gill, J., Gringeri, A., Growe, G. H., Guerois, C., & 26 autresHilgartner, M., Kasper, C. K., Kisker, C. T., Inwood, M. J., Magallon, F., Johnson, M. M., Mariani, G., Menza, L., Mauser-Bunschoten, E. P., Miller, R. T., Morfini, M., Nagao, T., Poon, M. C., Rasi, V., Rodeghiero, F., Rubin, S. H., Scharrer, I., Schimpf, K., Scheibel, E., Strawczyusky, H., Sultan, Y., Thompson, A. R., Tusell, J. M., White, G. C., Smith, P. & Walker, I., févr. 1996, Dans: Vox Sanguinis. 70, SUPPL. 1, p. 42-46 5 p.

  Medicine

  Résultat de recherche: Article › examen par les pairs
  13 Citations (Scopus)
• 1995

  Randomized trial of interferon maintenance in multiple myeloma: A study of the National Cancer Institute of Canada Clinical Trials Group

  Browman, G. P., Bergsagel, D., Sicheri, D., O'Reilly, S., Wilson, K. S., Rubin, S., Belch, A., Shustik, C., Barr, R., Walker, I., James, K., Zee, B. & Johnston, D., sept. 1995, Dans: Journal of Clinical Oncology. 13, 9, p. 2354-2360 7 p.

  Résultat de recherche: Article › examen par les pairs

  • National Cancer Institute (U.S.) 100%
  • Multiple Myeloma 85%
  • Interferons 79%
  • Canada 78%
  • Maintenance 60%
  94 Citations (Scopus)

• The Canadian Hemophilia Registry as the basis for a national system for monitoring the use of factor concentrates

  Walker, I. R., Akabutu, J. J., Ritchie, D. B., Growe, G. H., Poon, M. C., Card, R. T., Ali, S. K., Israels, S., Teitel, J. M., Garvey, B., Blanchette, V., Giles, A., Lillicrap, D., Drouin, J., Luke, B., Gill, K., Herst, J., Lépine‐Martin, M., Inwood, M., Rivard, G., & 11 autresStrawczynski, H., Jobin, F., Demers, C., Jardine, L., Whitman, L., Ingram, L., Robinson, S., Rubin, S., Scully, M. F., Dolan, S. & Ross, E., juill. 1995, Dans: Transfusion. 35, 7, p. 548-551 4 p.

  Medicine

  Résultat de recherche: Article › examen par les pairs

  • Hemophilia A 100%
  • Registries 69%
  • Government Programs 19%
  • Hemophilia B 17%
  • Federal Government 16%
  48 Citations (Scopus)